Cynata Therapeutics Limited Financial Overview
Cynata Therapeutics Limited's market cap is currently $41.86M. The company's EPS TTM is $-0.016322875; its P/E ratio is -5.14; Cynata Therapeutics Limited is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
